Conferences Cullinan Therapeutics is attending in 2026
LinkedIn cullinantherapeutics.com
Cullinan Therapeutics is listed at 3 conferences on Tnuki's calendar in 2026: PEGS Europe 2026 (on the program), ASH 2026 (on the program) and ACR Convergence 2026 (exhibiting). Cullinan Therapeutics is a biopharmaceutical company developing immunotherapies and targeted therapies for cancer and autoimmune diseases. As of Nov 12, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
PEGS Europe 2026 — Protein & Antibody Engineering SummitEurope’s protein & antibody engineersOfficial site |
Lisbon, Portugal ~1.5k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 keynote, 1 panel discussion, 1 talk
|
Open the guide Search and filter attendees |
ASH 2026 Annual Meeting & ExpositionHematologists & blood cancer researchersOfficial site |
New Orleans, LA ~30k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 poster
|
Open the guide Search and filter attendees |
ACR Convergence 2026Rheumatologists & autoimmune disease researchersOfficial site |
Past Orlando, FL ~15k attendees | ExhibitorAs published by American College of Rheumatology Booth 2930-CT, 2931-CT
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 66 of the 162 conferences on our calendar, so this page shows Cullinan Therapeutics’s involvement at those 66 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.